THE NICKLES GROUP, LLC for AMGEN
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 5376, The Build Better Back Act and issues regarding drug pricing. H.R. 3517 / S. 1943, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021. Issues related to the Self-Administered Drug (SAD) List.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Health Issues HCR
S. 4348, FDASLA Act of 2022 and H.R. 7667, Food and Drug Amendments of 2022. Issues regarding timely access to medications.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG D'ANGELO | — |
| MARY BETH SAVARY TAYLOR | — |
Government Issues GOV
H.R. 5376, The Build Better Back Act and issues regarding drug pricing. Issues regarding ESRD payments. H.R. 3517, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021. S. 4348, FDASLA Act of 2022 and H.R. 7667, Food and Drug Amendments of 2022. Issues related to the Self-Administered Drug (SAD) List. Issues related to self-administered drug designation. Issues related to timely access to medications. Issues related to cardiovascular disease.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETT BAKER | — |
Budget/Appropriations BUD
H.R. 8295, the Labor, HHS and Education Appropriations Bill and issues regarding cardiovascular disease.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARY BETH SAVARY TAYLOR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.